Relmada Therapeutics, Inc. (RLMD)
3.58
+0.14
(+4.07%)
USD |
NASDAQ |
Oct 30, 16:00
3.595
+0.02
(+0.42%)
After-Hours: 20:00
Relmada Therapeutics Price : 3.58 for Oct. 30, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | 3.42 | 3.655 | 3.30 | 3.58 | 1.414M |
| Oct 29, 2026 | 3.38 | 3.485 | 3.29 | 3.44 | 1.610M |
| Oct 28, 2026 | 3.21 | 3.36 | 3.18 | 3.35 | 1.615M |
| Oct 27, 2026 | 3.22 | 3.33 | 3.175 | 3.21 | 1.674M |
| Oct 26, 2026 | 3.30 | 3.305 | 3.215 | 3.23 | 775832.0 |
| Oct 23, 2026 | 3.26 | 3.335 | 3.18 | 3.27 | 1.101M |
| Oct 22, 2026 | 3.27 | 3.41 | 3.15 | 3.29 | 6.281M |
| Oct 21, 2026 | 3.35 | 3.395 | 3.19 | 3.21 | 1.721M |
| Oct 20, 2026 | 3.17 | 3.395 | 3.16 | 3.36 | 740282.0 |
| Oct 19, 2026 | 3.11 | 3.21 | 3.075 | 3.16 | 746309.0 |
| Oct 16, 2026 | 3.21 | 3.29 | 3.070 | 3.10 | 1.279M |
| Oct 15, 2026 | 3.27 | 3.35 | 3.185 | 3.20 | 909042.0 |
| Oct 14, 2026 | 3.31 | 3.37 | 3.195 | 3.24 | 1.354M |
| Oct 13, 2026 | 3.50 | 3.55 | 3.355 | 3.36 | 1.424M |
| Oct 12, 2026 | 3.39 | 3.535 | 3.315 | 3.51 | 1.424M |
| Oct 09, 2026 | 3.18 | 3.535 | 3.155 | 3.39 | 1.731M |
| Oct 08, 2026 | 3.23 | 3.32 | 3.10 | 3.17 | 1.886M |
| Oct 07, 2026 | 3.26 | 3.355 | 3.24 | 3.25 | 1.497M |
| Oct 06, 2026 | 3.50 | 3.50 | 3.265 | 3.28 | 1.736M |
| Oct 05, 2026 | 3.60 | 3.70 | 3.415 | 3.48 | 1.283M |
| Oct 02, 2026 | 3.72 | 3.73 | 3.60 | 3.60 | 1.210M |
| Oct 01, 2026 | 3.73 | 3.80 | 3.65 | 3.66 | 1.358M |
| Sep 30, 2026 | 3.78 | 3.845 | 3.72 | 3.77 | 999526.0 |
| Sep 29, 2026 | 3.82 | 3.89 | 3.695 | 3.73 | 863546.0 |
| Sep 28, 2026 | 3.80 | 3.855 | 3.71 | 3.79 | 986629.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ANI Pharmaceuticals, Inc. | 72.00 |
| Corcept Therapeutics, Inc. | 81.12 |
| Veru, Inc. | 2.19 |
| Johnson & Johnson | 273.20 |
| Eli Lilly & Co. | 1417.54 |
Price Related Metrics
| Price to Book Value | 1.849 |
| Earnings Yield | -25.98% |
| Market Cap | 381.88M |